March 3, 2021
NextGen researcher profile: Carolyn Anderson
Carolyn Anderson has spent more than 30 years developing targeted therapies for diseases like cancer and sickle cell disease. See how she will help drive research efforts for NextGen Precision Health.
Feb. 16, 2021
Key takeaways from the NextGen Precision Health Discovery Series kickoff
Here are 5 things you need to know from Richard Barohn’s Feb. 10 presentation.
Feb. 12, 2021
MU Research Reactor to supply radioisotope for targeted cancer therapy
The University of Missouri Research Reactor (MURR®) has entered into an exclusive multi-year agreement with Advanced Accelerator Applications International to provide a key ingredient in a targeted therapy for certain types of cancerous tumors.
Feb. 3, 2021
Probiotics or prebiotics? Exploring the complex world of ‘gut’ health
University of Missouri researchers develop a noninvasive way for identifying the major functions of the gastrointestinal tract.
Jan. 27, 2021
President Choi's testimony to legislators details university’s vast impact on Missouri
Funding for UM's core budget, NextGen Precision Health is critical for education, research and outreach
Jan. 12, 2021
Killing cancer by unleashing the body’s own immune system
University of Missouri scientists demonstrate a new bacteria-based strategy for turning the body’s own immune system against cancer.
Dec. 14, 2020
NextGen Precision Health brings together researchers from across the UM System
A December 2020 project update from Richard Barohn, executive director of NextGen Precision Health.
Dec. 7, 2020
Inclusive programs offer holistic support for diverse junior faculty
Collaborative initiatives build community and support the recruitment and retention of underrepresented faculty members at Mizzou.
Stay up-to-date on all things Mizzou when you subscribe to the Show Me Mizzou newsletter. Issues will arrive in your inbox every Tuesday, Wednesday and Thursday.Subscribe